| MolName | 2-hydroxy-N'-[6-[(5E)-5-[3-[6-[2-(2-hydroxybenzoyl)hydrazinyl]-6-oxohexyl]-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]hexanoyl]benzohydrazide |
| MolecularFormula | C32H34N6O8S4 |
| Smiles | Oc(cccc1)c1C(NNC(CCCCCN(C(/C(/S1)=C(/C(N2CCCCCC(NNC(c(cccc3)c3O)=O)=O)=O)\SC2=S)=O)C1=S)=O)=O |
| InChI | InChI=1S/C32H34N6O8S4/c39-21-13-7-5-11-19(21)27(43)35-33-23(41)15-3-1-9-17-37-29(45)25(49-31(37)47)26-30(46)38(32(48)50-26)18-10-2-4-16-24(42)34-36-28(44)20-12-6-8-14-22(20)40/h5-8,11-14,39-40H,1-4,9-10,15-18H2,(H,33,41)(H,34,42)(H,35,43)(H,36,44) |
| InChIK | YHIZHBWKAJHQML-UHFFFAOYSA-N |
| TotalMolweight | 758.92 |
| Molweight | 758.92 |
| MonoisotopicMass | 758.132094 |
| CLogP | 1.0772 |
| CLogS | -7.004 |
| H Acceptors | 14 |
| H Donors | 6 |
| TotalSurfaceArea | 552.58 |
| Relative PSA | 0.44946 |
| PolarSurfaceArea | 312.26 |
| Druglikeness | -3.0669 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | |
| Shape Index | 0.64 |
| Fragments | 1 |
| Non HAtoms | 50 |
| NonCHAtoms | 18 |
| Electronegative Atoms | 18 |
| Rotatable Bond | 16 |
| Rings Closures | 4 |
| Small Rings | 4 |
| Aromatic Rings | 2 |
| Aromatic Atoms | 12 |
| Sp3Atoms | 16 |
| Symmetricatoms | 25 |
| Amides | 2 |
| StereoCon |
Click to Load Molecule:
1 - 2-hydroxy-N'-[6-[(5E)-5-[3-[6-[2-(2-hydroxybenzoyl)hydrazinyl]-6-oxohexyl]-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]hexanoyl]benzohydrazide | 2 - 2-hydroxy-N'-[6-[(5E)-5-[3-[6-[2-(2-hydroxybenzoyl)hydrazinyl]-6-oxohexyl]-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]hexanoyl]benzohydrazide